Protective effects of a combination of salvia miltiorrhiza bunge and astragalus membranaceus bunge against concanavalin A-induced liver injury in rats: A biomechanical perspective
Abstract
Immune liver injury is a special type of chronic liver disease caused by immune dysfunction in the body. Salvia Miltiorrhiza (Danshen) and Astragalus membranaceus (Huangqi) have shown a synergistic effect in treating liver diseases in clinical settings. Nevertheless, the ideal combination ratio, dosage, and underlying mechanism of action of them remain uncertain. This research aimed to explore the biomechanical and immunological mechanisms of the combined use of Danshen and Huangqi in the treatment of liver injury, Which points to the regulation of lymphocyte biomechanics. To induce liver injury in rats, we administered Concanavalin A (ConA) via the tail vein. By observing liver indicators, serum biochemical indicators and liver tissue pathological changes in rats, the optimal ratio and dosage of the combination of “Danshen-Huangqi” was determined. Flow cytometry was used to analyze T lymphocyte subsets in rat peripheral blood. ELISA was performed to measure serum cytokine levels. RT-PCR was conducted to quantify specific transcription factors in rat aged 6–8 weeks liver tissue. Immunohistochemistry was utilized to evaluate the expression of apoptosis-related genes in rat liver tissue. The findings demonstrated that “Danshen-Huangqi” exerts bidirectional regulation on T lymphocyte subsets., influencing their biomechanical properties, such as cell stiffness and migratory behavior. The combination modulates the secretion of Th1, Th2, Th17, and Treg cytokines and specific transcription factors, thus rectifying the imbalance of Th1/Th2 and Th17/Treg (P < 0.05) lymphocyte subsets, but also inhibits atypical apoptosis of liver lymphocytes by controlling the expression of apoptosis-related genes in the rat liver with liver injury through the death receptor pathway and mitochondrial pathway. The biomechanical interactions of herbal remedies is to have a full effect on the protein molecules of target cells. Thus, the combination of Danshen and Huangqi may be a promising drug pair in improving liver injury. Compared with existing treatment options, this study is more mild and can be applied more widely in different populations.
References
1. Li N, Li B, Zhang J, et al, Protective effect of phenolic acids from Chebulae Fructus immaturus on carbon tetrachloride induced acute liver injury via suppressing oxidative stress, inflammation and apoptosis in mouse, Nat Prod Res. 34 (2020) 3249-3252, https://doi.org/10.1080/14786419.2018.1553174.
2. Ren, M., Lu, C., Zhou, M., Jiang, X., Li, X., & Liu, N. (2024). The intersection of virus infection and liver disease: A comprehensive review of pathogenesis, diagnosis, and treatment. WIREs Mechanisms of Disease, 16(3), e1640. https://doi.org/10.1002/wsbm.1640
3. Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS, Global burden of liver disease: 2023 update, J Hepatol. 79 (2023) 516-537, https://doi.org/10.1016/j.jhep.2023.03.017.
4. Hao, J., Sun, W., & Xu, H. (2022). Pathogenesis of concanavalin A induced autoimmune hepatitis in mice. International Immunopharmacology, 102, 108411. https://doi.org/10.1016/j.intimp.2021.108411
5. Wu S, Sa R, Gu Z, et al, The Protective Effect of Aesculus hippocastanum (Venoplant®) Against Concanavalin A-Induced Liver Injury, Pharmacology. 104 (2019) 196-206, https://doi.org/10.1159/000501258.
6. Wang Y, Chen J, Chen Y, Wu XT, Improvement of nonalcoholic fatty liver disease in ALT at ≥12 months after Roux-en-Y gastric bypass and sleeve gastrectomy, no effect in ALT and AST at <12 months after SG and in AST at >12 and ≤24 months after RYGB, Surg Obes Relat Dis. 16 (2020) 447-450, https://doi.org/10.1016/j.soard.2019.10.030.
7. Hwang W, Lee J, Pathophysiologic Implications of Cytokines Secretion during Liver Transplantation Surgery, Int J Med Sci. 15 (2018) 1737-1745, https://doi.org/10.7150/ijms.28382.
8. Wang L, Du H, Liu Y, Wang L, Ma X, Zhang W, Chinese medicine bu xu u ayu recipe for the regulation of treg/th17 ratio imbalance in autoimmune hepatitis, Evid Based Complement Alternat Med. 2015 (2015) 461294, https://doi.org/10.1155/2015/461294.
9. Song Y, Wu X, Yang D, et al, Protective Effect of Andrographolide on Alleviating Chronic Alcoholic Liver Disease in Mice by Inhibiting Nuclear Factor Kappa B and Tumor Necrosis Factor Alpha Activation, J Med Food. 23 (2020) 409-415, https://doi.org/10.1089/jmf.2019.4471.
10. Elshal M, Abu-Elsaad N, El-Karef A, Ibrahim T, Retinoic acid modulates IL-4, IL-10 and MCP-1 pathways in immune mediated hepatitis and interrupts CD4+ T cells infiltration, Int Immunopharmacol. 75 (2019) 105808, https://doi.org/10.1016/j.intimp.2019.105808.
11. Tian X, Liu Y, Liu X, Gao S, Sun X, Glycyrrhizic acid ammonium salt alleviates Concanavalin A-induced immunological liver injury in mice through the regulation of the balance of immune cells and the inhibition of hepatocyte apoptosis, Biomed Pharmacother. 120 (2019) 109481, https://doi.org/10.1016/j.biopha.2019.109481.
12. Wang K, Molecular mechanisms of hepatic apoptosis regulated by nuclear factors, Cell Signal. 27 (2015) 729-738, https://doi.org/10.1016/j.cellsig.2014.11.038.
13. Alhusaini AM, Faddah LM, Hasan IH, et al, Vitamin C and Turmeric Attenuate Bax and Bcl-2 Proteins’ Expressions and DNA Damage in Lead Acetate-Induced Liver Injury, Dose Response. 17 (2019) 1559325819885782. https://doi.org/10.1177/1559325819885782.
14. Zhou Y, Chen K, He L, et al, The Protective Effect of Resveratrol on Concanavalin-A-Induced Acute Hepatic Injury in Mice, Gastroenterol Res Pract. 2015 (2015) 506390, https://doi.org/10.1155/2015/506390.
15. Fernandes P, O’Donnell C, Lyons C, et al, Intestinal expression of Fas and Fas ligand is upregulated by bacterial signaling through TLR4 and TLR5, with activation of Fas modulating intestinal TLR-mediated inflammation, J Immunol. 193 (2014) 6103-6113, https://doi.org/10.4049/jimmunol.1303083.
16. Heymann F, Hamesch K, Weiskirchen R, Tacke F, The concanavalin A model of acute hepatitis in mice, Lab Anim. 49 (2015) 12-20, https://doi.org/10.1177/0023677215572841.
17. Yue S, Hu B, Wang Z, et al, Salvia miltiorrhiza compounds protect the liver from acute injury by regulation of p38 and NFκB signaling in Kupffer cells, Pharm Biol. 52 (2014) 1278-1285, https://doi.org/10.3109/13880209.2014.889720.
18. Shi MJ, Dong BS, Yang WN, Su SB, Zhang H, Preventive and therapeutic role of Tanshinone ⅡA in hepatology, Biomed Pharmacother. 112 (2019) 108676, https://doi.org/10.1016/j.biopha.2019.108676.
19. Alam P, Parvez MK, Arbab AH, Al-Dosari MS, Quantitative analysis of rutin, quercetin, naringenin, and gallic acid by validated RP- and NP-HPTLC methods for quality control of anti-HBV active extract of Guiera senegalensis, Pharm Biol. 55 (2017) 1317-1323, https://doi.org/10.1080/13880209.2017.1300175.
20. Chen LY, Sun TT, Zhu D, et al, Protective Mechanism of Astragalus Ⅳ Combined with Salvianolic Acid B on Hepatocyte ( HHL － 5) Peroxidation Injury, Liaoning Journal of Traditional Chinese Medicine, 46 (2019) 1488-1490+1569, http://dx.doi.org/10.13192/j.issn.1000-1719.2019.07.042.
21. Xie D, Zhou P, Liu L, et al, Protective Effect of Astragaloside IV on Hepatic Injury Induced by Iron Overload, Biomed Res Int. 2019 (2019) 3103946, https://doi.org/10.1155/2019/3103946.
22. Jiang Z, Zheng L, Magnesium isoglycyrrhizinate protects against concanavalin A-induced immunological liver injury in a mouse model, Rev Rom Med Lab. 27 (2019) 281-290, https://doi.org/10.2478/rrlm-2019-0026.
23. Getachew Y, Cusimano FA, James LP, Thiele DL, The role of intrahepatic CD3+/CD4-/CD8- double negative T (DN T) cells in enhanced acetaminophen toxicity, Toxicol Appl Pharmacol. 280 (2014) 264-271, https://doi.org/10.1016/j.taap.2014.08.017.
24. Su L, Wu Z, Chi Y, et al, Mesenteric lymph node CD4+ T lymphocytes migrate to liver and contribute to non-alcoholic fatty liver disease, Cell Immunol. 337 (2019) 33-41, https://doi.org/10.1016/j.cellimm.2019.01.005.
25. Rao J, Cheng F, Yang S, Zhai Y, Lu L, Ag-specific CD4 T cells promote innate immune responses in liver ischemia reperfusion injury, Cell Mol Immunol. 16 (2019) 98-100, https://doi.org/10.1038/s41423-018-0051-x.
26. Liu HM, Han YZ, Guo YM, et al, The protection effects of Liuweiwuling tablets against concanavalin A-induced acute immunological liver injury in mice, Chin Pharmacol Bull. 33 (2017) 133-140, https://doi.org/10.3969/j.issn.1001-1978.2017.01.023.
27. Yang C, Cui F, Chen LM, Gong XY, Qin B, Correlation between Th17 and nTreg cell frequencies and the stages of progression in chronic hepatitis B, Mol Med Rep. 13 (2016) 853-859, https://doi.org/10.3892/mmr.2015.4618.
28. Akberova D, Kiassov AP, Abdulganieva D, Serum Cytokine Levels and Their Relation to Clinical Features in Patients with Autoimmune Liver Diseases, J Immunol Res. 2017 (2017) 9829436, https://doi.org/10.1155/2017/9829436.
29. Gong Y, Liu H, Tao L, Cajanonic acid A regulates the ratio of Th17/Treg via inhibition of expression of IL-6 and TGF-β in insulin-resistant HepG2 cells [retracted in: Biosci Rep. 2022 Jan 28;42(1):], Biosci Rep. 39 (2019) BSR20181716, https://doi.org/10.1042/BSR20181716.
30. Cho J, Kim S, Yang DH, et al, Mucosal Immunity Related to FOXP3+ Regulatory T Cells, Th17 Cells and Cytokines in Pediatric Inflammatory Bowel Disease, J Korean Med Sci. 33 (2018) e336, https://doi.org/10.3346/jkms.2018.33.e336.
31. Tan Y, Chen W, Liu C, Zheng X, Guo A, Long J, Effect of IL-21 on the Balance of Th17 Cells/Treg Cells in the Pathogenesis of Graves’ Disease, Endocr Res. 44 (2019) 138-147, https://doi.org/10.1080/07435800.2019.1600535.
32. Zhu K, Ye J, Wu M, Cheng H, Expression of Th1 and Th2 cytokine-associated transcription factors, T-bet and GATA-3, in peripheral blood mononuclear cells and skin lesions of patients with psoriasis vulgaris, Arch Dermatol Res. 302 (2010) 517-523, https://doi.org/10.1007/s00403-010-1048-1.
33. Cubero FJ, Woitok MM, Zoubek ME, de Bruin A, Hatting M, Trautwein C, Disruption of the FasL/Fas axis protects against inflammation-derived tumorigenesis in chronic liver disease, Cell Death Dis. 10 (2019) 115, https://doi.org/10.1038/s41419-019-1391-x.
34. Zhu H, Berkova Z, Mathur R, et al, HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer, Mol Cancer Res. 13 (2015) 809-818, https://doi.org/10.1158/1541-7786.MCR-14-0241.
35. Berger RML, Weck JM, Kempe SM, et al. Nanoscale FasL Organization on DNA Origami to Decipher Apoptosis Signal Activation in Cells. Small. 2021;17(26):e2101678. Doi:10.1002/smll.202101678
36. Abou Shousha S, Baheeg S, Ghoneim H, Zoheir M, Hemida M, Shahine Y. The effect of Fas/FasL pathway blocking on apoptosis and stemness within breast cancer tumor microenvironment (preclinical study). Breast Dis. 2023;42(1):163-176. Doi:10.3233/BD-220077
37. Qian, S., Wei, Z., Yang, W., Huang, J., Yang, Y., & Wang, J. (2022). The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Frontiers in oncology, 12, 985363. https://doi.org/10.3389/fonc.2022.985363
38. Gitego, N., Agianian, B., Mak, O.W. et al. Chemical modulation of cytosolic BAX homodimer potentiates BAX activation and apoptosis. Nat Commun 14, 8381 (2023). https://doi.org/10.1038/s41467-023-44084-3
39. Kaloni D, Diepstraten ST, Strasser A, Kelly GL. BCL-2 protein family: attractive targets for cancer therapy. Apoptosis. 2023;28(1-2):20-38. doi:10.1007/s10495-022-01780-7
Copyright (c) 2025 Tong Guan, Jian Fan, Feng Guan, Yanhong Wang
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright on all articles published in this journal is retained by the author(s), while the author(s) grant the publisher as the original publisher to publish the article.
Articles published in this journal are licensed under a Creative Commons Attribution 4.0 International, which means they can be shared, adapted and distributed provided that the original published version is cited.
Submit a Paper
